Co-targeting of FAK and MDM2 triggers additive anti-proliferative effects in mesothelioma via a coordinated reactivation of p53.
about
A link between the fibroblast growth factor axis and the miR-16 family reveals potential new treatment combinations in mesothelioma.Heterogeneous Contributing Factors in MPM Disease Development and Progression: Biological Advances and Clinical Implications.Good Guy or Bad Guy? The Duality of Wild-Type p53 in Hormone-Dependent Breast Cancer Origin, Treatment, and Recurrence.Emerging Medical Treatments for Meningioma in the Molecular Era
P2860
Co-targeting of FAK and MDM2 triggers additive anti-proliferative effects in mesothelioma via a coordinated reactivation of p53.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Co-targeting of FAK and MDM2 t ...... ordinated reactivation of p53.
@en
type
label
Co-targeting of FAK and MDM2 t ...... ordinated reactivation of p53.
@en
prefLabel
Co-targeting of FAK and MDM2 t ...... ordinated reactivation of p53.
@en
P2093
P2860
P356
P1476
Co-targeting of FAK and MDM2 t ...... ordinated reactivation of p53.
@en
P2093
Grant Eilers
Hai-Meng Zhou
Hailong Li
Jiongyan Ding
Jonathan A Fletcher
Qing Sheng
Wen-Bin Ou
P2860
P2888
P304
P356
10.1038/BJC.2016.331
P407
P577
2016-10-13T00:00:00Z
P6179
1038447031